ArticleBioengineered2021

LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.

Mingkun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.